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Paxillinphosphatases (RPTPs) have been shown to play key roles in regulating axon
guidance and synaptogenesis. HmLAR2, one of two closely related LAR-like RPTPs in the embryonic leech, is
expressed in a few central neurons and in a unique segmentally-iterated peripheral cell, the comb cell (CC).
Here we show that tagged HmLAR2-EGFP has a punctate pattern of expression in the growth cones of the CC,
particularly at the tips of extending ﬁlopodia. Moreover, although expression of the wild-type EGFP-tagged
receptor does not affect CC growth cone morphology, expression of a putative dominant-negative mutant of
the receptor, CS-HmLAR2, leads to the enlargement of the growth cones, a shortening of ﬁlopodia, and errors
in cellular tiling. RNAi of several candidate substrate signaling proteins, Lena (leech Ena/Vasp), β-integrin and
paxillin, but not β-catenin, phenocopies particular aspects of the effects of HmLAR2 RNAi. For paxillin, which
co-localizes with HmLAR2 at growth cone puncta, knock-down led to a reduction in the number of such
puncta. Together, our data suggests that HmLAR2 regulates the morphology of the growth cone by
controlling F-actin polymerization and focal adhesion complexes.
© 2008 Elsevier Inc. All rights reserved.IntroductionMechanistically, the directed growth and navigation of neuronal
processes within an embryo may be viewed as resulting from the
combined dynamic regulation of cytoskeletal extension and differ-
ential cell adhesion by the motile structure at the end of a growing
neurite — the growth cone. Among the receptors suspected to play a
role in this guidance are the receptor protein tyrosine phosphatases
(RPTPs; reviewed in Johnson and Van Vactor (2003), Ensslen-Craig
and Brady-Kalnay (2004)). Studies have shown that many RPTPs are
localized to differentiating invertebrate and vertebrate growth cones
(Tian et al., 1991; Bodden and Bixby, 1996; Gershon et al., 1998a;
Honkaniemi et al., 1998). The RPTPs alongwith their partnered protein
tyrosine kinases (PTKs) have been shown to regulate many of the Rho
GTPases (Debant et al., 1996; Bateman et al., 2000; Major and Brady-
Kalnay, 2007), and the Ena/Vasp family of phosphotyrosine proteins
(Wills et al., 1999), both of which are known mediators of ﬁlopodial
extension and cell adhesion (Meyer and Feldman, 2002). Studies have
also revealed that RPTPs are localized with adhesion sites (both
integrin and cadherin-based) and help to regulate the stability of these
sites, including those found on growing neurons and during
synaptogenesis (Brady-Kalnay et al., 1995; Serra-Pages et al., 1995;
Fuchs et al., 1996; Aicher et al., 1997; Helmke et al., 1998; Zhen and Jin,
1999; Dunah et al., 2005).l rights reserved.In the medicinal leech, two LAR-like RPTPs are expressed during
development in select neurons, muscles, and in a unique bilaterally
and segmentally-reiterated template cell, the comb cell (CC; Gershon
et al., 1989a). Past experiments have shown that perturbing the
functions of the CC RPTP, designated HmLAR2, with injections of
antibodies recognizing the receptor ectodomain (Gershon et al.,
1998b), recombinant ectodomain proteins (Baker et al., 2000), or
RNAi (Baker and Macagno, 2000a,b) leads to growth cone collapse, a
loss of self-avoidance, and errors in cellular tiling. While additional
observations have suggested that HmLAR2 probably acts on actin
polymerization through a Ena/Vasp substrate (Biswas et al., 2002).
These ﬁndings, together with the observation that the receptor's
ectodomain is capable of homophilic binding via its NH2-terminal Ig
domains (Baker et al., 2000), have led to the hypothesis that cellular
tiling by the CC is the result of a self-avoidance interaction mediated
by HmLAR2 which signals the local retraction of cellular processes
upon contact with a neighboring process (Baker and Macagno,
2000b).
Here we describe the distribution of a EGFP-tagged HmLAR2
receptor in the growth cones of the CC. Our results show that the
transgene is localized as puncta in the growth cone and at the tips of
the ﬁlopodia. RNAi of putative signaling proteins downstream to
HmLAR2with single cell dsRNA injections in the embryo revealed that
knock-down of expression of Lena (leech Ena/Vasp), or the integrin
adhesion-site proteins β-integrin and paxillin, phenocopies different
aspects of HmLAR2 RNAi, suggesting that HmLAR2 helps regulate
growth cone morphology through F-actin control and focal adhesion-
site regulation.
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Expression constructs and embryo injection
Full-length HmLAR2 and a truncated HmLAR2 ectodomain with just EGFP after the
transmembrane region (nucleotide 1–4539;HmLAR2-ECD; accessionnumber AF017083)
were generated by PCR and subcloned into expression constructs made from a modiﬁed
EGFP-N1 (Clontech) vector inwhich theCMVpromoterwas excised and thepromoter of a
leech cytoplasmic actin gene, HmAct1, was inserted in its place (Baker and Macagno,
2006). For generation of CS-HmLAR2 constructs, primers were designed for site-directed
mutagenesis of C1684→S using standard procedures (Sambrook et al., 1989). In order to
visualize the ectodomain ofHmLAR2 independently of the EGFP intracellular tag, we also
used PCR site-directed mutagenesis to engineer an HA epitope tag (YPYDVPDYA) at the
N-terminal of HmLAR2, just after the signal sequence, using overlapping and
complementary oligonucleotides. Expression constructs of paxillin and Lena (accession
numbers EU675626 and AY007501) clones were made by subcloning into a modiﬁed
EGFP-C3 plasmid (Clontech) in which the EGFP was replaced with the red ﬂuorescent
protein mCherry (kindly provided by R. Tsien, University of California San Diego, La Jolla,
CA). To investigate tyrosine phosphorylation in growth cones of the CC, we generated a
ﬂuorescent PY reporter construct (Kirchner et al., 2003) consisting of tandem PY-binding
SH2 domains of a leech c-src (accession number EU675628) fused to mCherry. Plasmid
DNA (~2 μg/μl) was dissolved in a solution of 10 mMHepes (pH 7.4) and 10 mMKCl with
0.5% Alexa 488 or 568 dextran (Molecular Probes) to visualize the injectate.
RNA interference
Knock-down of selected genes was accomplished by injecting siRNAsmade using the
Silencer siRNA Cocktail kit (Ambion) into the CCs as previously described (Baker and
Macagno, 2000a,b). Two siRNAswere used forHmLAR2, one encompassing nucleotides 1–
1650 which we had used in previous experiments, and the other with only 5′-UTR
sequence (bp-153-0), which we used in conjunction with the expression of HmLAR2
constructs lacking these 5′-UTR sequences to test recovery of function when the
endogenous RPTP was replaced with the artiﬁcial protein. In addition, siRNAs were made
from full-length sequences of the leech orthologs of enabled (Lena), paxillin, gelsolin
(EU675623), proﬁling (EU675624), and β-catenin (EU675627).
Experimental animals
Leech embryos used in these experiments were obtained from a Hirudo medicinalis
colony maintained in our laboratory. Prior to use, they were removed from their
cocoons and kept in artiﬁcial spring water (0.5 g/l Instant Ocean, Aquarium Systems) at
22 °C, and staged according to the criteria of Fernandez and Stent (1982). At this
temperature, day 0 (E0) is deﬁned as the day of cocoon deposition and day 30 (E30) as
the day of emergence of the juvenile animal from the cocoon.
Immunocytochemistry and in situ hybridizations on whole-mount embryos
Anti-GFP an HA immunocytochemistry was performed on whole-mount embryos
using a directly conjugated Alexa 488, rabbit anti-GFP (Molecular Probes) and amonoclonal
anti-HA (A2095; Sigma) and an anti-mouse, conjugated Alexa 568 or 633 (Molecular
Probes) using established methods (Baker et al., 2000). Anti-HA immunoﬂuorescence was
also performed using a Tyramide-Alexa 555, HRP signal ampliﬁcation technique
(Invitrogen). In some experiments, phalloidin Alexa 568 (Molecular Probes) was used to
counterstain the muscles and cell layers of the germinal plate. In other experiments, PY99
(Santa Cruz Biotechnology), was used as a general marker of phosphotyrosyl levels and
localization. The effectiveness of all RNAi knock-down injectionswas conﬁrmed through in
situ hybridization staining (Nardelli-Haeﬂiger and Shankland, 1993).
Growth cone measurements and analysis
Analyses of ﬁlopodial lengths and life spans were performed using maximum-
intensity projections of z-stacks using Metamorph Imaging software. Filopodial lengths
were deﬁned as the distance from the base of the ﬁlopodium to its tip. Analysis was
restricted to ﬁlopodia that were singularly identiﬁable at their base. An approximate
measure of growth cone size was determined by measuring the width of the growth
cone at its broadest point while excluding the ﬁlopodia. Two-tailed unpaired Student's t
tests were performed for statistical signiﬁcance (pb0.05).
Generation of an antiserum recognizing HmLAR2
A polyclonal antiserum was raised against the terminal FNIII domain of HmLAR2.
Rabbits were injected with a glutathione S-transferase (GST) fusion of HmLAR2 made
by PCR cloning in-frame nucleotides 3102–3360 of HmLAR2 into pGEX-2T (Amersham
Biosystems). Rabbits were commercially injected with puriﬁed recombinant protein
and the resulting serum afﬁnity puriﬁed according to standard protocols (Harlow and
Lane 1988).
Western blot analysis
CHO-K20 Chinese hamster cells were grown in F12 media (Invitrogen) and
transfected with HmLAR2 cDNA constructs using Fugene 6 (Rhoche). For assessment ofHmLAR2 ectodomain cleavage, the supernatant and pellet from 100 mm conﬂuent
plates were collected and immunoprecipitated with anti-HA complexed with protein G
and immunoblotted with anti-HA as described previously (Biswas et al., 2002).Results
In the leech embryo, HmLAR2 is expressed at high levels in the
growth cones of the comb cell (CC). CCs are found bilaterally near the
ventral surface of the body wall, in each somatic segment of the
developing medicinal leech (Jellies and Kristan, 1988, 1991; Fig. 1C).
Located between the outer circular and inner longitudinal muscle
layers, the spindle-shaped soma of a CC aligns along the anterior–
posterior axis and produces approximately 70 obliquely oriented
processes, each bearing a large growth cone at the tip. Beginning at
about mid-embryogenesis, these processes grow rapidly, with those
on the lateral surface of the cell extending antero-laterally and those
on the medial surface extending postero-medially, with the left and
right cells of a segmental pair showing mirror symmetry and one of
the bilateral homologues extending beneath the other (Baker and
Macagno, 2007). The growth cones in these diagonal arrays follow
straight, parallel paths as they expand to the full width of the germinal
plate, very rarely branching or overlapping, although some distortion
occurs as they grow around physical obstacles in their path, such as
the nephridiopores. After acting as templates or scaffolds for the
establishment of the oblique musculature, the CCs appear to undergo
apoptosis late in embryogenesis (Jellies and Kristan, 1988, 1991;
Gershon et al., 1998b).
Design and in vitro testing of tagged and mutated HmLAR2 constructs
In order to examine the distribution and role of HmLAR2 in the
growth cones of the CC, we expressed, in situ, different HmLAR2
cDNA receptor constructs in individual CCs during development. A
full-length HmLAR2 clone was obtained by PCR from cDNA made
from puriﬁed whole Hirudo embryo mRNA. Sequencing conﬁrmed
the identity of this clone with the original HmLAR2 sequence
obtained from piecing together multiple overlapping clones from an
adult CNS cDNA library (Gershon et al., 1998a). In order to visualize
the receptor we engineered a doubly-tagged construct, with an
EGFP transcript at the 3′ end and an HA epitope sequence at the 5′
end (diagrammed in Fig. 1A). Expression of this clone was tested in
CHO cells and yielded a single protein of ~250 kDa (Fig. 1B), in good
agreement with the predicted molecular mass of HmLAR2 (224 kDa)
plus EGFP (~24 kDa). When a lysate of CHO cells expressing the full-
length receptor construct was immunoblotted using an antiserum
recognizing the membrane proximal FNIII domain of HmLAR2, a
band above 250 kDa was also revealed (Fig. 1B), further demon-
strating that the full-length receptor can be expressed using the
tagged clone.
To help assay the functions of the endodomain and its effect on
localization, a doubly-tagged construct lacking the intracellular
catalytic domains of the receptor was also made (diagram, Fig. 1A).
Transfection of CHO cells with the plasmid containing this truncated
HmLAR2-EGFP construct resulted, as predicted, in a protein of
approximately 200 kDa when the lysate was probed with anti-HA
(Fig. 1B). Further, to distinguish between two putative roles of the
endodomain (substrate binding and phosphatase activity), a full-
length enzymatically inactive HmLAR2 construct, CS-HmLAR2, was
engineered by substituting a single amino acid (C1684→S) in the ﬁrst
intracellular phosphatase domain of the receptor (diagram, Fig. 1A).
Based on work by others on RPTPs in different systems (Streuli et al.,
1990; Pot et al., 1991; Jia et al., 1995; Krueger et al., 2003), this
modiﬁed receptor is predicted to act in a dominant-negative fashion,
loosing virtually all its phosphatase activity but retaining the ability to
bind substrates. The results of expressing these three constructs in CCs
are presented in the next sections.
Fig. 1. Comb cell growth cone morphology following normal and mutant HmLAR2-EGFP expression. (A) A diagram of the HmLAR2-EGFP expression construct. An HA epitope tag was
inserted after the signal sequence to label the NH2-terminal end of the receptor. HmLAR2-ECD comprising just the extracellular domain (ECD) of HmLAR2, and HmLAR2-CS is a
predicted catalytically null construct (with C1654 in the ﬁrst phosphatase domain switched to a S (Pot et al., 1991)). (B) Immunoblot of CHO cells lysate after transient transfectionwith
the full-length cDNA or ECD construct showing a band at ~250 kDa and 180 kDa respectively. Lanes 1–3 labeled with an anti-HA antiserum. Lanes 4 and 5 are the same lysates as in
lane 2 but labeled without and with an antiserum recognizing the ﬁnal FNIII extracellular domain. (C) Comb cell expression of HmLAR2-EGFP in 2 segmental homologues at around
mid-embryogenesis (E12). Note the many orthogonal parallel processes seen emanating from the spindle-shaped central cell body (arrowheads). Each process is tipped by a large
growth cone (not in focal plane, see D). Arrow at midline indicates dorsal CNS. (D) Close-up views of CC growth cones after expressing the HmLAR2 constructs for 48 h. (a) EGFP and
HA immunoﬂuorescence (b) reveals a concentration of the receptor in the growth cone, particularly in the C-domain. Many of the ﬁlopodia also display a speckled, punctate labeling
with EGFP, particularly at their tips (arrowheads). This pattern was repeated with the HA receptor ectodomain (HA-tag red; arrowheads), but was also observed independently of
EGFP label (arrows) particularly in the central process near the growth cone (c; arrows) but also extending retrogradely back towards the cell body. (d) Growth cone expression of
HmLAR2-ECD. No punctate distribution and both the HA-tagged ectodomain and the EGFP-tagged transmembrane label appear co-localized throughout the growth cone and
especially along the surface membrane (f; yellow double-labeling). (g) HmLAR2-CS expression was heavily clustered in prominent puncta, particularly at the tips of many of the
characteristically short and stubby ﬁlopodia (arrowheads). These EGFP-rich puncta were also positive for the HA-ectodomain (h–i), and unlike normal HmLAR2 expression, the CS
mutant expression showed little evidence for the separation of the ectodomain and endodomain labels (arrows). Scale bar=100 µm in C, 5 µm in D. (E–G) Quantiﬁcation of CC growth
cone morphology following expression of the different HmLAR2 constructs (⁎⁎pb0.01; ⁎⁎⁎pb0.001, data are means plus SD).
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cone puncta
To examine the distribution of the tagged receptor in CCs, the CMV
promoter used for expression in CHO cells was replaced with the
promoter of HmAct1, a leech cytoplasmic actin gene that is expressed
at high levels in embryonic neurons and in the CCs (Baker and
Macagno, 2006). In vivo injection into a CC's nucleus of the full-length
HA-HmLAR2-EGFP construct yielded detectable receptor expression 1
to 2 days after injection (Fig. 1C). The tagged HmLAR2 protein could
also be visualized with an antibody to the HA epitope (see Materials
and methods) without prior detergent permeabilization of cell
membranes, indicating that the receptor's ectodomain is found on
the surface of the CCs and suggesting that the receptor is inserted
correctly in the membrane (data not shown).
We assayed whether adding the expression of ectopic HmLAR2 to
the expression of the endogenous receptor affected experimental CCsby comparing the growth cones of cells expressing the full-length
constructs with those of adjacent control cells injected with
ﬂuorescent dyes. Measurements of ﬁlopodial lengths, grouped into
either those projecting forward, ahead of the growth cone, or those on
the sides of the growth cone and projecting laterally, revealed no
signiﬁcant differences (pN0.05; n=46) among either class of ﬁlopodia
(see Figs. 1E, F). Similarly, neither growth cone size, represented by
cross-sectional diameter (see Fig. 1G), nor rate of process extension
(~0.3 mm/day, Baker and Macagno, 2007; data not shown), showed a
signiﬁcant difference between HmLAR2-EGFP expressing cells and
control cells injected with ﬂuorescent dextran. We conclude that
either the level of ectopic expression is a relatively minor addition to
the very signiﬁcant level of endogenous expression of HmLAR2 in the
CCs, or that there is a compensatory reduction in the level of
endogenous expression. Another possibility is that the amount of
HmLAR2 in CC growth cones is not highly regulated and can vary
substantially within a normal range. Whichever is the case, the data
Fig. 2. HmLAR2-CS expression produced characteristic errors in CC tiling. (A) Growth cones after 24 h of expressing normal full-length HmLAR2 and HmLAR2-CS (B) constructs. The
mutated receptor leads to an enlargement of the growth cone area and a shortening of many of the ﬁlopodia. Prominent receptor puncta, especially at the tips of the stunted ﬁlopodia,
are common. (C) HmLAR2-EGFP and HmLAR2-CS expression (D) after 48 h. The body wall musculature has been stained with Alexa 568 conjugated phalloidin. Many of the growth
cones expressing the CS-mutated receptor show cross-over errors and aberrant trajectories. Scale bar=5 µm in A and B, 10 µm in C and D.
Fig. 3. Phosphotyrosine and HmLAR2-EGFP labeling in the CC growth cones. Expression of full-length HmLAR2 EGFP (A) and mCherry-SH2d (B) and the resulting double-label (C).
Unlike the punctate HmLAR2 expression in the growth cone and along individual ﬁlopodia (arrows), mCherry-SH2d expression is observed to be mostly even and diffuse in the C-
domain of the growth cone with little signal found in the ﬁlopodia. (D, E) Whereas, expression of the HmLAR2-CS construct leads to a punctate labeling by the PY indicator,
particularly at HmLAR2-CS puncta in the ﬁlopodia (arrows). Scale bar=5 µm.
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otherwise normal receptor, while the expression of tagged modiﬁed
receptors can have signiﬁcant effects, as documented below.
Close examination of the distribution of the tagged receptor
through either its intracellular or extracellular tags revealed two
interesting and novel features. When visualized through the EGFP tag,
the ectopic receptor, like the endogenous receptor (Gershon et al.,
1998a, b), was found to be concentrated at the CC growth cones,
especially in the central domain (C-domain), along the lamellipodial
edge and along ﬁlopodia. Unexpectedly, however, we also observed
receptors clustered in small puncta, particularly at the tips of
ﬁlopodia (Fig. 1D, Panels a and b arrowheads). Comparison with
the distribution of the exogenous receptor visualized through its HA-
ectodomain epitope, revealed almost complete overlap, but with a
notable exception: granular ectodomain labeling was clearly
observed by itself in many locations, most prominently in the central
area of the processes, proximal to the more dynamic areas of the
growth cone (Fig. 1D, Panels b and c, arrows; Baker and Macagno,
2007). This physical separation of some HA-tagged ectodomains from
the corresponding GFP-tagged endodomains suggests that for a
subset of the HmLAR2 proteins, the ectodomain may be post-
translationally cleaved, as reported previously for mammalian RPTPs
(Streuli et al., 1992; Gebbink et al., 1995), and perhaps subsequently
internalized.
Signiﬁcantly different results were obtained when the receptor
construct lacking the phosphatase endodomain, HmLAR2-ECD was
expressed in CCs. For example, while HmLAR2-ECD was observed to
be concentrated in the growth cones with a distribution similar to that
of the full-length construct, no clustering in puncta was detected with
either tag (Fig. 1D, Panels d and e), both labels appearing uniformlyFig. 4. HmLAR2 RNAi leads to growth cone collapse, errors in navigation and a zigzag-like m
dsRNA for HmLAR2. The body wall musculature (longitudinal muscles marked by single wh
phalloidin. (B) Growth cone collapse and numerous cross-over errors are evident, as well a
reconstruction of the confocal stack revealing that some of the CC processes have extended o
body wall (arrowhead). Scale bar=12 µm. (D) Comb cell process extension following HmLAR2
body following intracellular injections of HmLAR2 dsRNA, HmNetrin dsRNA or the vehicle alo
case HmNetrin and vehicle controls were performed on the contralateral CC homolog (n=5).
after 48 and 72 h, a signiﬁcant reduction in process lengths were observed (⁎⁎⁎pb0.001, twalong the growth conemembrane and along ﬁlopodia (compare ﬁgure
(cf) Panels a to d and b to e, Fig. 1D). Also notable was the complete
absence of separate endodomain and ectodomain granules (cf. Panels
c and f, Fig. 1D), suggesting that the ectodomain ofHmLAR2-ECD is not
cleaved. Despite these major differences in tagged receptor distribu-
tions, themorphology of CCs expressing the truncated receptor was as
normal as that of CCs expressing the full-length receptor when
compared to a dye-ﬁlled cell (Figs. 1E–G).
A still different result followed expression of the tagged full-length
but catalytically null receptor construct, CS-HmLAR2. As discussed
above, this mutant receptor lacks essentially all phosphatase activity
but retains the ability to bind cytoplasmic substrates. Twenty four to
forty eight hours after injection of the mutated receptor DNA, there
were noticeable changes in themorphology of the CC growth cone and
in the trajectory of its processes (Figs. 2B, D). For example, the
ﬁlopodia (both those at the leading edge and on the sides) of CS-
HmLAR2-expressing CCs were signiﬁcantly shorter in length and
stubby in appearance (Figs. 1E, F), while the average diameters of the
growth cones were signiﬁcantly larger in comparison with dye-ﬁlled
control cells (Fig. 1G; cf. Panels A and B in Fig. 2). Many of the CS-
HmLAR2-expressing growth cones were also bifurcated, crossing
over their neighboring process and taking abnormal trajectories
(panels B and D, Fig. 2), thus making errors similar to those seen
following HmLAR2 RNAi (Baker and Macagno, 2000a,b).
Interestingly, the expression of CS-HmLAR2, like the expression of
the normal HmLAR2 shows aggregation of the receptor into puncta,
including puncta at the tips of ﬁlopodia. However, there was no
obvious evidence of the separation of extracellular and intracellular
labels as observed for the wild-type HmLAR2 receptor (cf. Panels c, f
and i, Fig. 1D).orphology. (A) Alexa 488 dextran ﬂuorescent labeling of a CC 48 h after injection with
ite asterisks and circular muscle fascicles) has been stained with Alexa 568 conjugated
s a distinctively bent or zigzagged appearance along most of the processes (B). (C) 3-D
ut from between the longitudinal and circular muscle layers towards the surface of the
RNAi. Total CC process length was measured from the growth cone tips back to the cell
ne (2% Alexa 488 dextran in Hepes KCl buffer). Injections were performed at E10. In each
No differences were seen in process length between the groups at 12 or 24 h, whereas,
o-tailed t test comparing HmLAR2 RNAi treatment to either HmNetrin or vehicle).
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activity
As expected for an abundantly expressed and widely distributed
tyrosine phosphatase, RNAi knock-down of HmLAR2 expression in a
CC leads to a readily observed increase in protein tyrosine phosphor-
ylation (PY) levels throughout the cell, as detected with a commer-
cially available α-PY antibody (Baker and Macagno, 2000a,b). The
observation (presented in the previous section) that the expressed CS-
HmLAR2 receptor aggregates in puncta at the tips of shortened
ﬁlopodia (Fig. 3B) raises the questionwhether this clustering results in
local increases of PY levels that might be the basis for some of the
observed abnormalities of CCs expressing the catalytically null
receptor.
To investigate in ﬁne spatial detail how expression of either
HmLAR2-EGFP or CS-HmLAR2-EGFP affects levels of PY and its spatial
distribution at the growth cone, we co-expressed in individual CCs
one of the receptor constructs and a ﬂuorescent PY reporter constructFig. 5. In vivo images of CC growth cones 24 or 48 h after RNAi of HmLAR2 or various putative
to visualize the growth cones. (B) 48 h after HmLAR2 RNAi injection (using dsRNA correspon
collapse and bifurcations. (C) Transgene rescue is apparent following HmLAR2 5′-UTR dsR
receptor-EGFP construct was injected into the CC's nucleus. Note that despite the apparent co
loss of ﬁlopodia. Also note the presence of puncta along and at the tips of ﬁlopodia (cf. Fig. 1D,
Ena/Vasp) RNAi. Growth cones show signs of collapse (loss of lamellipodial surface area) an
catenin RNAi injection, the CCs has no apparent effects on the CC growth cones and processe
like appearance to the cell processes. Despite this, however, the growth cones themselves aconsisting of tandem PY-binding SH2 domains (from a leech c-src
gene identiﬁed in our laboratory) fused to the mCherry ﬂuorophore
(mCherry-SH2d; Kirchner et al., 2003). In CCs expressing both normal
full-length HmLAR2-EGFP (Fig. 3A) and the reporter (Fig. 3B), strong
mCherry-SH2d label was diffusely distributed throughout the pro-
cesses and the C-domain of the growth cones. When present in
ﬁlopodia, mCherry-SH2d label was generally faintly distributed along
the entire ﬁlopodial shaft, but was not detectable in puncta at the
ﬁlopodial tip (Figs. 3A–C; arrows). In contrast, when the reporter was
co-expressed with the CS-HmLAR2 receptor, a concentration of
mCherry-SH2d label was observed to co-localize with receptor puncta
throughout the growth cone, but was particularly apparent at the tips
of many of the short ﬁlopodia (Figs. 3D–F; arrows).
To conﬁrm the speciﬁcity of mCherry-SH2d labeling, we also
examined its co-localization with PY-speciﬁc immunostaining. The PY
distributions detected with these two methods were found to be
highly spatially correlated, as has been previously conﬁrmed in other
preparations (Kirchner et al., 2003; Robles et al., 2005). Comb cellsdownstream signaling proteins to HmLAR2. (A) Control dye-ﬁll with Alexa 488 dextran
ding to the 5′-UTR of the endogenous receptor). Note the loss of ﬁlopodia, growth cone
NA injection. At the same time as the cytoplasmic injection of dsRNA, the full-length
llisions between some of the growth cones, there is no collapsing, zigzagging or obvious
panel a). (D) Alexa 488 dextran ﬂuorescent labeling of CC growth cones after Lena (leech
d there is a reduction in the number of ﬁlopodia and a partial zigzag-like effect. (E) β-
s. (F) After β-integrin RNAi injection, by comparison, there is a pronounced zigzagging-
ppear quite normal. Scale bar=10 µm.
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immunostaining in the growth cone C-domain, but for the most part,
PY-like immunoreactivity was absent or low in the ﬁlopodia and at
HmLAR2-positive puncta (Supplemental Fig. 1). Such staining resem-
bles that seen normally in the CC growth cones using the same
antibody (Baker and Macagno, 2000a,b). Comb cells expressing the
CS-HmLAR2-EGFP plasmid had lower overall levels of PY-staining, but
in many of the ﬁlopodia, particularly those where CS-HmLAR2 puncta
were found, PY-like immunoreactivity was high and appeared to be
co-localized with or very near the puncta, as was observed with the
mCherry-SH2d reporter.
Together, these data indicate that normal PY dynamics in the CC's
ﬁlopodia and growth cone puncta were below the detection limits of
the PY ﬂuorescent reporter and antibody. However, with the
expression of the CS-HmLAR2 construct, the puncta become hyper-
tyrosine phosphorylated and clearly visible. Such an interruption in
normal PY regulation in the puncta may account for the CS-HmLAR2
phenotype: an enlarged growth cone with short and stumpy ﬁlopodia
and a loss of cellular self-avoidance.
RNAi of HmLAR2 and putative HmLAR2-associated proteins
We previously demonstrated that knock-down of HmLAR2 by
injection of dsRNA into a CC results in ﬁlopodial retraction and growth
cone collapse within about a day (Baker and Macagno, 2000a,b). To
assay these effects further, we have now extended the time after
injection and observed several additional effects, which are docu-
mented in Fig. 4. As previously described, HmLAR2 RNAi leads to the
collapse of most of the CC growth cones and a virtual total loss of
ﬁlopodia. Additionally, there were many instances where the
processes failed to maintain their equidistant and parallel spacing
between the longitudinal and circular muscle layers and crossed over
one another. In fact, after waiting 48 h some of the cell's processes
were observed to have extended perpendicularly out of this planeFig. 6. Quantiﬁcation of CC growth cone morphology following receptor RNAi and HmLAR2 tr
quantifying growth cone diameter, number of cross-over errors (instances inwhich one proc
and the number of bends in the CC process (instances of bending by the process of more th
Co-expression of HmLAR2-EGFP with HmLAR2 5′ UTR dsRNAs leads to a signiﬁcant reco
diameter decrease and process bending/zigzagging while producing a smaller but not stati
RNAi of several proteins known to associate with LAR RPTPs, on growth cone diameter, num
to growth cone collapse and numerous cross-over errors by the CC, whereas, RNAi of Hm
Asterisks denote signiﬁcant differences from control dye-ﬁlls (⁎⁎pb0.01; ⁎⁎⁎pb0.001; datbetween the longitudinal and circular muscles and towards the
surface of the bodywall (arrowhead in Fig. 4C). The additional day also
revealed that most of the CC processes had adopted a zigzagged or
corkscrew-like appearance. This phenotype, hereafter referred to as
‘zigzag’, is suggestive of a loss of attachment sites between the growth
cone and its surrounding parenchyma or extracellular matrix and is
examined further below.
Examining the effects of HmLAR2 RNAi over several days also
permitted us to quantify the effects of receptor knock-down on the
rate of CC process extension. This was done bymeasuring total process
length from the tips of the growth cone back to the cell body of
bilaterally-paired CCs — with one of the cells receiving the dsRNA
injection for the receptor and the other paired contralateral cell being
injected with either dsRNA for leech netrin, a gene which is not
expressed by the CC (Gan et al., 1996), or the vehicle control. Total CC
extension was then followed from around E10 to E13, a 3 day period
which immediately proceeds and overlaps the rapid phase of CC
extension as the processes grow to encircle the developing germinal
plate (Jellies and Kristan, 1988, 1991). For the ﬁrst 24 h, no differences
were observed in the process length (Fig. 5D). However, by 48 h a
signiﬁcant decrease in length was evident which became more
pronounced by 72 h (pb0.001, n=5 cells each). Interestingly, despite
the decrease in process extension brought about by HmLAR2 RNAi,
extension was not altogether halted, but continued, although at a
signiﬁcantly reduced rate.
To conﬁrm that the HmLAR2 RNAi phenotypes, (a) collapsed
growth cones, (b) process cross-over and (c) process zigzagging, are
the result of a loss of HmLAR2 and not some other ‘off-target’ effects
(e.g. Alvarez et al., 2006), we examined the consequences of
‘transgene rescue’, in which the endogenous receptor in CCs was
targeted by injecting siRNAs made against the 5′-UTR of the receptor
while simultaneously expressing HmLAR2-EGFP in the cell (using a
cDNA which lacks the endogenous receptor's UTRs). As compared to
control CCs (vehicle plus EGFP, HmLAR2-EGFP or intracellular Alexaansgene rescue, and RNAi of putative HmLAR2-associated signaling proteins. (A) Graphs
ess intersects another - errors were counted only for the distal-most 50 μm of a process),
an 20 degrees for the distal-most 50 μms as a measure of the degree of zigzag effect).
very from the two effects of HmLAR2 knock-down, reducing both the growth cone
stically signiﬁcant reduction in cross-over errors. (B) Graphs quantifying the effects of
ber of cross-over errors and bends in the CC process. RNAi of HmLAR2 and Lena lead
LAR2, Lena, Paxillin and β-Integrin lead to the zigzagging of the cellular processes.
a plotted are means plus SD).
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dsRNAs directed towards the 5′-UTR of HmLAR2 demonstrated a
pronounced growth cone collapsing phenotype and a signiﬁcant
increase in the number of cross-over errors and bends or zigzagging of
their cellular processes (Fig. 5B). However, targeting the 5′-UTR did
not appear to be as efﬁcient as targeting the coding region of the
mRNA (the degree of growth cone collapse and number of cross-over
and zigzagging errors were all signiﬁcantly less when targeting the 5′-
UTR (pb0.001 for all measures; data not shown). Interestingly, when
the 3′-UTR of the receptor was targeted, little to no knock-down
effects were observed (data not shown).
When a rescuing transgene was co-injected along with the 5′-UTR
siRNAs, a signiﬁcant recovery was observed for the growth cone
collapsing and zigzagging effects but not for the number of cross-over
errors (Figs. 5C, 6A). As with expression of the tagged receptor in CCs
not treated with dsRNA, HmLAR2-EGFP in dsRNA-treated cells was
found to be concentrated in the growth cone C-domain and as puncta
in the ﬁlopodia. In all the measures assayed, rescued cells were not
signiﬁcantly different from control dye-injected, EGFP and HmLAR2
expressing CCs.
These data strongly support the conclusion that the growth cone
collapse and zigzagging are direct effects of knocking down or
eliminating HmLAR2 function in the CC. The fact that cross-over
errors were still evident, despite transgene expression, is postulated to
reﬂect a dosage effect, whereby navigation errors by the processes of
the CC are much more sensitive to changing RPTP levels.
With these two phenotypic markers (growth cone collapse and
zigzag) in mind, we conducted RNAi screens of candidate HmLAR2-
interacting proteins in the expectation that, if knocking out a given
protein phenocopies, at least in part, the HmLAR2 RNAi phenotype,
then the candidate protein would warrant further testing for
participation in a common signaling pathway with HmLAR2. An
examination of F-actin modulating proteins conﬁrmed our past
biochemical evidence suggesting a central role for Lena (leech Ena/
Vasp; Biswas et al., 2002). RNAi of Lena leads to both the loss of growth
cone ﬁlopodia and a less severe but observable zigzag appearance (Fig.
5D). RNAi of either a leech proﬁlin or the F-actin capping protein
gelsolin decreased the rate of CC process outgrowth but had no
obvious morphological effect at the level of the growth cone
(Supplemental Fig. 3). Assays of candidate cellular adhesion-site
proteins revealed that, whereas β-catenin RNAi had no observable
effects (Fig. 5E), RNAi of either β-integrin (Fig. 5F) or the adaptor
protein paxillin (not shown) produced a clear zigzag phenotype, but
without a signiﬁcant effect on growth cone morphology (see Table 1).Table 1
Comb cell gene expression and resulting RNAi phenotype
Leech protein CC expression as
revealed by in
situ hybridization
RNAi phenotype upon
intracellular injection
of siRNAsa
Neuronal
expression
HmLAR2 + GCb collapse, zigzag, +
↓extension
Lena (Ena/Vasp) + GC collapse, zigzag, +
↓extension
Trio – NDc +
Liprin-α + – +
RACK – ND +
Gelsolin + ↓extension +
Proﬁlin + ↓extension +
Β-integrin + zigzag, +
↓extension
Paxillin + zigzag, +
↓extension
Β-catenin + – +
Echinoid + – +
a Based on CC morphology 24–48 h after injection.
b GC = growth cone.
c ND = not done.RNAi of other known RPTP substrates, such as the adaptor proteins
TRIO, Liprin or RACK (Debant et al., 1996; Serra-Pages et al., 1998;
Mourton et al., 2001; Kaufmann et al., 2002), produced no detectable
effects (Table 1). Knock-down of HmLAR2, Lena, paxillin and other
mRNAs were veriﬁed by in situ hybridizations (shown for paxillin in
Supplemental Fig. 2; data not shown for others).
Quantiﬁed results of these RNAi experiments are presented
graphically in Fig. 6B. The data show that a statistically signiﬁcant
decrease in growth cone diameter and increase in the frequency of
cross-over errors relative to controls occurred only as a consequence
of HmLAR2 or Lena knock-down. By comparison, statistically sig-
niﬁcant numbers of zigzags per unit length of process resulted from
RNAi of paxillin and β-integrin, as well as HmLAR2 and Lena. We
concluded from these observations that HmLAR2 might be playing
two roles in regulating CC growth characteristics, one affecting Lena
phosphorylation and thus F-actin polymerization, and the other as a
required component of FA sites during process outgrowth.
Leech paxillin co-localizes with HmLAR2 at ﬁlopodial puncta and affects
its distribution
Our results showing that knock-down of FA proteins β-integrin or
paxillin produces a zigzag phenotype like that of the knock-down of
HmLAR2 prompted us to examine the distribution of FA sites in the
CC growth cones.We generated a leech paxillin ﬂuorescent-tag fusion,
paxillin-mCherry, and co-expressed it with HmLAR2-EGFP. The
paxillin-mCherry protein was found to co-localize with much of the
HmLAR2-EGFP signal in the growth cone, especially in the receptor
puncta in ﬁlopodia and in the growth cone C-domain (Figs. 7A–C).
Thus, HmLAR2 appears to be localized to or near focal complex
sites linking the growth cone with the surrounding extracellular
matrix.
Lastly, we asked whether the distribution of HmLAR2 in the
growth cones of the CC changes following RNAi of paxillin. We would
predict that if the punctate receptor distribution is due to its being
localized with integrin FAs, then knocking out these sites with paxillin
RNAi may lead to the dispersion of the puncta. The presence and
distribution of receptor punctawere assayed 48 h after injection of the
HmLAR2 expression construct by itself or together with siRNAs for
either β-catenin or paxillin. As shown in Fig. 7, receptor puncta were
present following β-catenin (panel D) but not after paxillin RNAi
(panel E). In the latter case, punctate labeling was absent from the
ﬁlopodia, and only a few densely labeled clusters were detectable in
growth cones' C-domains and in the distal regions of CC processes.
Nonetheless, growth cones appeared normal in size and ﬁlopodial
number (Fig. 7F), although many were conspicuously bent or crooked
in appearance (Fig. 7E, arrows).
Together, these data suggest that the normal clustering of HmLAR2
receptor at FA sites involves an interaction that requires the presence
of paxillin. Knock-down of paxillin leads to the re-distribution of the
receptor and the disappearance of receptor puncta in the CC growth
cones.
Discussion
LAR-like RPTPs associate with and regulate adhesion sites
The presence of HmLAR2 in the tip puncta of CC growth cone
ﬁlopodia is not unexpected, given the growing body of evidence
implicating LAR-like RPTPs and their signaling partners in the
regulation of cell–cell and cell–matrix adhesion sites (Serra-Pages
et al., 1995; Fuchs et al., 1996; Aicher et al., 1997; Helmke et al., 1998;
Bateman et al., 2001; Dunah et al., 2005). Drosophila LAR, for
example, has been shown to associate with FAs in oocytes (Bateman
et al., 2001) and cultured cells (Hofmeyer et al., 2006). Likewise,
mammalian LAR can associate with both FA and cadherin–catenin
Fig. 7. Paxillin is co-expressed in many of the HmLAR2 growth cone puncta. Expression of HmLAR2-EGFP (A) and mCherry-paxillin (B) and the resulting double-labeling (C). (D)
Growth cones expressing HmLAR2 48 h after injection of the expression construct and β-catenin dsRNA. Note the strong punctate distribution of the receptor. (E) HmLAR2-EGFP
distribution 48 h after injection with paxillin dsRNA. Virtually all puncta have disappeared (a few remain in the C-domain and proximal process) and the receptor appears evenly
distributed along the ﬁlopodia and growth cone. Red arrows indicate abnormally bent ﬁlopodia. (F) Growth cone ﬁlopodia number, their length and the number ofHmLAR2-puncta in
each ﬁlopodium, 48 h after injection with the HmLAR2 expression construct alone, or with β-catenin or paxillin dsRNA. Data are mean±SD. ⁎⁎⁎pN0.001. Scale bar=5 µm.
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Reichardt, 1996). Known catalytic targets for LARs include both β-
catenin and cadherin, which have been reported to be directly
dephosphorylated by human LAR (Dunah et al., 2005; Siu et al.,
2007). In contrast, LAR-like RPTPs have been thought to target
phosphoproteins associated with integrin adhesion sites indirectly
by dephosphorylating/activating Src-like tyrosine kinases, including
focal adhesion kinase (Wills et al., 1999; Tsujikawa et al., 2002;
Medley et al., 2003; Yang et al., 2005). Finally, mammalian LAR has
been suggested to be highly concentrated at focal complex sites
which are presumed to be undergoing disassembly (Serra-Pages et
al., 1995), which would be consistent with the proposed role for
HmLAR2 as a mediator of self-repulsion.LAR-like RPTPs are indirect regulators of the actin cytoskeleton
CC growth cone collapse and ﬁlopodial retraction are outcomes of
HmLAR2 knock-down that reﬂect a massive depolymerization of the
actin cytoskeleton. Exposure of CCs to Cytochalasin B produces
substantially similar structural changes, as would be expected
(Baker and Macagno, 2007). LAR-like RPTPs are known to affect the
state of the growth cone actin cytoskeleton, acting indirectly via LAR
substrates such as the Ena/Vasp family of proteins. Some of these
proteins have been shown to bind directly to the LAR D2 domain
(Wills et al., 1999) and, in both the ﬂy and the leech, to be
dephosphorylated by the catalytically active D1 domain (Wills et al.,
1999; Biswas et al., 2002). Ena/Vasp proteins stably localize to
224 M.W. Baker et al. / Developmental Biology 320 (2008) 215−225ﬁlopodial tips and are associated with the barbed-ends of F-actin, and,
in at least some situations, their phosphorylation promotes ﬁlopodial
formation and extension (Mejillano et al., 2004; Lebrand et al., 2004).
Ena/VASP proteins also bind to the focal adhesion proteins zyxin and
vinculin and are enriched at sites of cell–substratum contact
(Reinhard et al., 1992; 1996). It is therefore perhaps not surprising
that RNAi of Lena phenocopies both of the effects observed following
HmLAR2 RNAi, growth cone and ﬁlopodial collapse as well as the
zigzag phenotype, conﬁrming a role for Lena in focal complex sites
through F-actin regulation.
The CS-RPTP mutation is believed to act as a dominant-negative
factor, either by interfering with the endogenous receptor (perhaps
through dimerization; van der Wijk et al., 2005; Tonks, 2006), or by
acting in a substrate-trapping manner (Jia et al., 1995). Indeed, a
substrate-trapping mechanism might explain how a null tyrosine
phosphatase could trap and block the regulated dephosphorylation of
punctal proteins. Interestingly, the effects of CS-HmLAR2 expression
differ considerable from those of HmLAR2 RNAi. These differences
may reveal attributes of the endogenous receptor's function. For
example, while perhaps the most striking among the effects of
receptor RNAi is growth cone collapse (Baker and Macagno, 2000a,b),
this is never observed after CS-HmLAR2 expression; in fact, we
observed that CS expression in individual CCs led to a signiﬁcant
enlargement of the growth cones' central domains. Both RNAi and CS
construct expression lead to the hyperphosphorylation of tyrosine
protein residues in the growth cone. However, unlike RNAi, which
appears to produce a general, seemingly uniform, increase in anti-PY
immunostaining in the affected growth cones (Baker and Macagno,
2000a,b), CS-HmLAR2 expression leads to pronounced hyperpho-
sphorylation in the FA puncta but not in the C-domain. These
differences may reﬂect a dosage effect, with CS-HmLAR2 expression
causing a partial inhibitory effect versus RNAi producing a full knock-
down/inhibition. Alternatively, HmLAR2 may have dual functions:
ﬁrst, ectodomain signaling, with which the expression of CS-HmLAR2
does not interfere, and second, the regulated dephosphorylation of
tyrosine residues, which is perturbed by the CS mutation. Receptor
RNAi, however, interferes with both roles. This scenario is supported
by the observation that a partial rescue can be achieved among Dro-
sophila photoreceptor cells after DLAR RNAi by expressing just the
receptor's ectodomain (Maurel-Zaffran et al., 2001; Krueger et al.,
2003), or of DLAR knock-out embryonic lethality by expressing just
the NH2-terminal Ig domains of the receptor (Krueger et al., 2003).
Likewise, the restoration of adhesivity in a prostate cancer cell line can
be accomplished by expressing a CS version of RPTPμ (Hellberg et al.,
2003), suggesting again a role for RPTPs independent of catalytic
action.
HmLAR2 and comb cell growth and cellular tiling
The evidence presented here, and in previous publications from
our laboratory, clearly implicatesHmLAR2 in CC process extension and
growth cone dynamics. A key remaining question, however, is
whether signaling by this RPTP is directly responsible for controlling
arbor tiling by the ensemble of CCs. Various lines of evidence have led
us to propose that it does so indeed, through a homophilic binding
interaction that mediates self- and homolog-recognition and the local
retraction of ﬁlopodia and branches away from points of contact or
overlap between parts of the cells (Baker and Macagno, 2000a,b;
Baker et al., 2000; Baker and Macagno, 2007). Alternatively, HmLAR2
might affect downstream signaling components, which in turn are
necessary for regulating integrin adhesion and F-actin polymerization.
Critical clues may come from a time-lapse analysis of the de-novo
appearance and fate of receptor clusters in relation to the extensions
and retractions of growth cone ﬁlopodia, and the behavior of those
ﬁlopodia and their puncta upon acute application of receptor
ectodomain proteins. Such experiments would allow the testing ofpotential ligand binding and extracellular signaling on the behavior of
the growth cones.
Whichever turns out to be the case, it is of interest to note that
HmLAR2, like DSCAM a family of molecules that have been recently
implicated in the mediation of self-avoidance and arbor tiling through
homophilic binding in insects and vertebrates (e.g. Hughes et al.,
2007; Mathews et al., 2007; Soba et al., 2007; Millard et al., 2007;
Fuerst et al., 2008), is a member of the immunoglobulin superfamily
(IgSF) of cell adhesion molecules. These various IgSF members share
the ectodomain structural feature of possessing Ig and FIII domains, in
different numbers but with the former generally distally located, and
the functional feature of displaying homophilic binding properties
that subtends the key property of self-recognition. They differ
signiﬁcantly, however, in their intracellular domains, which lends to
each unique capacities for calling upon different signaling pathways.
In the case of HmLAR2, the intracellular domain appears to bring into
play both focal adhesion and cytoskeletal regulatory signaling into
play, as shown in this report.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.ydbio.2008.05.522.
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